市场调查报告书

静脉支架的全球市场

Venous Stents

出版商 Global Industry Analysts, Inc. 商品编码 956929
出版日期 内容资讯 英文 382 Pages
商品交期: 最快1-2个工作天内
价格
静脉支架的全球市场 Venous Stents
出版日期: 2020年09月01日内容资讯: 英文 382 Pages
简介

全球静脉支架的市场规模在2020年~2027年的分析期间中预计将以8.5%的年复合成长率增长,从2020年的9亿1,900万美元到2027年达到16亿美元。市场区隔之一的髂骨静脉支架部门在分析期间结束前预测将以8.5%的年率增长,达到11亿美元的规模。

本报告提供全球静脉支架市场的相关调查,提供市场占有率,趋势和预测,成长要素,各地区的市场分析,竞争情形,主要企业的简介等资讯。

调查对象企业范例

  • BARD, A Becton, Dickinson Company
  • Boston Scientific Corporation
  • Cook Medical LLC
  • Gore Medical
  • Jotec GmbH
  • OptiMed Medizinische Instrumente GmbH

目录

I. 简介,调查手法 、 调查范围

II. 摘要整理

  • 市场概要
    • 竞争的市场占有率
    • 竞争的市场占有率方案
    • Covid-19的影响和即将到来的全球景气衰退
  • 主要企业
  • 趋势与成长要素
  • 全球市场预测

III. 市场分析

  • 各地区市场分析
  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 南美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他南美国家
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯联合大公国
  • 其他中东
  • 非洲

IV. 竞争

  • 企业简介:43公司
目录
Product Code: MCP16887

Global Venous Stents Market to Reach $1.6 Billion by 2027

Amid the COVID-19 crisis, the global market for Venous Stents estimated at US$919 Million in the year 2020, is projected to reach a revised size of US$1.6 Billion by 2027, growing at aCAGR of 8.5% over the period 2020-2027. Iliac Vein Stent Technology, one of the segments analyzed in the report, is projected to record 8.5% CAGR and reach US$1.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Wallstent Technology segment is readjusted to a revised 8.6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $248.5 Million, While China is Forecast to Grow at 11.5% CAGR

The Venous Stents market in the U.S. is estimated at US$248.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$337.8 Million by the year 2027 trailing a CAGR of 11.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.7% and 7.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 6.6% CAGR.We bring years of research experience to this 5th edition of our report. The 382-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • BARD, A Becton, Dickinson Company
  • Boston Scientific Corporation
  • Cook Medical LLC
  • Gore Medical
  • Jotec GmbH
  • OptiMed Medizinische Instrumente GmbH

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Global Competitor Market Shares
    • Venous Stents Competitor Market Share Scenario Worldwide (in %): 2019 &
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Venous Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 2: World Historic Review for Venous Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 3: World 15-Year Perspective for Venous Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Iliac Vein Stent Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 5: World Historic Review for Iliac Vein Stent Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 6: World 15-Year Perspective for Iliac Vein Stent Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Wallstent Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 8: World Historic Review for Wallstent Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 9: World 15-Year Perspective for Wallstent Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Leg by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 11: World Historic Review for Leg by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 12: World 15-Year Perspective for Leg by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Chest by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 14: World Historic Review for Chest by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 15: World 15-Year Perspective for Chest by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Abdomen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 17: World Historic Review for Abdomen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 18: World 15-Year Perspective for Abdomen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Arm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 20: World Historic Review for Arm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 21: World 15-Year Perspective for Arm by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Chronic Deep Vein Thrombosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 23: World Historic Review for Chronic Deep Vein Thrombosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 24: World 15-Year Perspective for Chronic Deep Vein Thrombosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 25: World Current & Future Analysis for Post Thrombotic Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 26: World Historic Review for Post Thrombotic Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 27: World 15-Year Perspective for Post Thrombotic Syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 28: World Current & Future Analysis for May-Thurner Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 29: World Historic Review for May-Thurner Syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 30: World 15-Year Perspective for May-Thurner Syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 31: World Current & Future Analysis for Hemodialysis/Arteriovenous Fistulae by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 32: World Historic Review for Hemodialysis/Arteriovenous Fistulae by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 33: World 15-Year Perspective for Hemodialysis/Arteriovenous Fistulae by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 34: World Current & Future Analysis for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 35: World Historic Review for Other Disease Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 36: World 15-Year Perspective for Other Disease Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Venous Stents Market Share (in %) by Company: 2019 &
    • Market Analytics
    • TABLE 37: USA Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 38: USA Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 39: USA 15-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2012, 2020 & 2027
    • TABLE 40: USA Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 41: USA Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 42: USA 15-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2012, 2020 & 2027
    • TABLE 43: USA Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 44: USA Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 45: USA 15-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 46: Canada Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 47: Canada Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 48: Canada 15-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2012, 2020 & 2027
    • TABLE 49: Canada Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 50: Canada Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 51: Canada 15-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2012, 2020 & 2027
    • TABLE 52: Canada Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 53: Canada Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 54: Canada 15-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 55: Japan Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 56: Japan Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 57: Japan 15-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2012, 2020 & 2027
    • TABLE 58: Japan Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 59: Japan Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 60: Japan 15-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2012, 2020 & 2027
    • TABLE 61: Japan Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 62: Japan Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 63: Japan 15-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 64: China Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 65: China Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 66: China 15-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2012, 2020 & 2027
    • TABLE 67: China Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 68: China Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 69: China 15-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2012, 2020 & 2027
    • TABLE 70: China Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 71: China Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 72: China 15-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2012, 2020 & 2027
  • EUROPE
    • Market Facts & Figures
    • European Venous Stents Market: Competitor Market Share Scenario (in %) for 2019 &
    • Market Analytics
    • TABLE 73: Europe Current & Future Analysis for Venous Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 74: Europe Historic Review for Venous Stents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 75: Europe 15-Year Perspective for Venous Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 76: Europe Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 77: Europe Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 78: Europe 15-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2012, 2020 & 2027
    • TABLE 79: Europe Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 80: Europe Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 81: Europe 15-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2012, 2020 & 2027
    • TABLE 82: Europe Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 83: Europe Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 84: Europe 15-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 85: France Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 86: France Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 87: France 15-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2012, 2020 & 2027
    • TABLE 88: France Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 89: France Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 90: France 15-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2012, 2020 & 2027
    • TABLE 91: France Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 92: France Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 93: France 15-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 94: Germany Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 95: Germany Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 96: Germany 15-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2012, 2020 & 2027
    • TABLE 97: Germany Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 98: Germany Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 99: Germany 15-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2012, 2020 & 2027
    • TABLE 100: Germany Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 101: Germany Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 102: Germany 15-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 103: Italy Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 104: Italy Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 105: Italy 15-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2012, 2020 & 2027
    • TABLE 106: Italy Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 107: Italy Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 108: Italy 15-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2012, 2020 & 2027
    • TABLE 109: Italy Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 110: Italy Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 111: Italy 15-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 112: UK Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 113: UK Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 114: UK 15-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2012, 2020 & 2027
    • TABLE 115: UK Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 116: UK Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 117: UK 15-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2012, 2020 & 2027
    • TABLE 118: UK Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 119: UK Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 120: UK 15-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2012, 2020 & 2027
  • SPAIN
    • TABLE 121: Spain Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 122: Spain Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 123: Spain 15-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2012, 2020 & 2027
    • TABLE 124: Spain Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 125: Spain Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 126: Spain 15-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2012, 2020 & 2027
    • TABLE 127: Spain Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 128: Spain Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 129: Spain 15-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2012, 2020 & 2027
  • RUSSIA
    • TABLE 130: Russia Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 131: Russia Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 132: Russia 15-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2012, 2020 & 2027
    • TABLE 133: Russia Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 134: Russia Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 135: Russia 15-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2012, 2020 & 2027
    • TABLE 136: Russia Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 137: Russia Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 138: Russia 15-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 139: Rest of Europe Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 140: Rest of Europe Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 141: Rest of Europe 15-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2012, 2020 & 2027
    • TABLE 142: Rest of Europe Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 143: Rest of Europe Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 144: Rest of Europe 15-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2012, 2020 & 2027
    • TABLE 145: Rest of Europe Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 146: Rest of Europe Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 147: Rest of Europe 15-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 148: Asia-Pacific Current & Future Analysis for Venous Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 149: Asia-Pacific Historic Review for Venous Stents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 150: Asia-Pacific 15-Year Perspective for Venous Stents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
    • TABLE 151: Asia-Pacific Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 152: Asia-Pacific Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 153: Asia-Pacific 15-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2012, 2020 & 2027
    • TABLE 154: Asia-Pacific Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 155: Asia-Pacific Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 156: Asia-Pacific 15-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2012, 2020 & 2027
    • TABLE 157: Asia-Pacific Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 158: Asia-Pacific Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 159: Asia-Pacific 15-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2012, 2020 & 2027
  • AUSTRALIA
    • TABLE 160: Australia Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 161: Australia Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 162: Australia 15-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2012, 2020 & 2027
    • TABLE 163: Australia Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 164: Australia Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 165: Australia 15-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2012, 2020 & 2027
    • TABLE 166: Australia Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 167: Australia Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 168: Australia 15-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2012, 2020 & 2027
  • INDIA
    • TABLE 169: India Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 170: India Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 171: India 15-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2012, 2020 & 2027
    • TABLE 172: India Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 173: India Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 174: India 15-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2012, 2020 & 2027
    • TABLE 175: India Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 176: India Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 177: India 15-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2012, 2020 & 2027
  • SOUTH KOREA
    • TABLE 178: South Korea Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 179: South Korea Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 180: South Korea 15-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2012, 2020 & 2027
    • TABLE 181: South Korea Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 182: South Korea Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 183: South Korea 15-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2012, 2020 & 2027
    • TABLE 184: South Korea Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 185: South Korea Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 186: South Korea 15-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2012, 2020 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 187: Rest of Asia-Pacific Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 188: Rest of Asia-Pacific Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 189: Rest of Asia-Pacific 15-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2012, 2020 & 2027
    • TABLE 190: Rest of Asia-Pacific Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 191: Rest of Asia-Pacific Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 192: Rest of Asia-Pacific 15-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2012, 2020 & 2027
    • TABLE 193: Rest of Asia-Pacific Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 194: Rest of Asia-Pacific Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 195: Rest of Asia-Pacific 15-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2012, 2020 & 2027
  • LATIN AMERICA
    • TABLE 196: Latin America Current & Future Analysis for Venous Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 197: Latin America Historic Review for Venous Stents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 198: Latin America 15-Year Perspective for Venous Stents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
    • TABLE 199: Latin America Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 200: Latin America Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 201: Latin America 15-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2012, 2020 & 2027
    • TABLE 202: Latin America Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 203: Latin America Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 204: Latin America 15-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2012, 2020 & 2027
    • TABLE 205: Latin America Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 206: Latin America Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 207: Latin America 15-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2012, 2020 & 2027
  • ARGENTINA
    • TABLE 208: Argentina Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 209: Argentina Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 210: Argentina 15-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2012, 2020 & 2027
    • TABLE 211: Argentina Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 212: Argentina Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 213: Argentina 15-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2012, 2020 & 2027
    • TABLE 214: Argentina Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 215: Argentina Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 216: Argentina 15-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2012, 2020 & 2027
  • BRAZIL
    • TABLE 217: Brazil Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 218: Brazil Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 219: Brazil 15-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2012, 2020 & 2027
    • TABLE 220: Brazil Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 221: Brazil Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 222: Brazil 15-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2012, 2020 & 2027
    • TABLE 223: Brazil Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 224: Brazil Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 225: Brazil 15-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2012, 2020 & 2027
  • MEXICO
    • TABLE 226: Mexico Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 227: Mexico Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 228: Mexico 15-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2012, 2020 & 2027
    • TABLE 229: Mexico Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 230: Mexico Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 231: Mexico 15-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2012, 2020 & 2027
    • TABLE 232: Mexico Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 233: Mexico Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 234: Mexico 15-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2012, 2020 & 2027
  • REST OF LATIN AMERICA
    • TABLE 235: Rest of Latin America Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 236: Rest of Latin America Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 237: Rest of Latin America 15-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2012, 2020 & 2027
    • TABLE 238: Rest of Latin America Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 239: Rest of Latin America Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 240: Rest of Latin America 15-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2012, 2020 & 2027
    • TABLE 241: Rest of Latin America Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 242: Rest of Latin America Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 243: Rest of Latin America 15-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2012, 2020 & 2027
  • MIDDLE EAST
    • TABLE 244: Middle East Current & Future Analysis for Venous Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 245: Middle East Historic Review for Venous Stents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 246: Middle East 15-Year Perspective for Venous Stents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
    • TABLE 247: Middle East Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 248: Middle East Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 249: Middle East 15-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2012, 2020 & 2027
    • TABLE 250: Middle East Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 251: Middle East Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 252: Middle East 15-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2012, 2020 & 2027
    • TABLE 253: Middle East Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 254: Middle East Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 255: Middle East 15-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2012, 2020 & 2027
  • IRAN
    • TABLE 256: Iran Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 257: Iran Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 258: Iran 15-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2012, 2020 & 2027
    • TABLE 259: Iran Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 260: Iran Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 261: Iran 15-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2012, 2020 & 2027
    • TABLE 262: Iran Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 263: Iran Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 264: Iran 15-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2012, 2020 & 2027
  • ISRAEL
    • TABLE 265: Israel Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 266: Israel Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 267: Israel 15-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2012, 2020 & 2027
    • TABLE 268: Israel Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 269: Israel Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 270: Israel 15-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2012, 2020 & 2027
    • TABLE 271: Israel Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 272: Israel Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 273: Israel 15-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2012, 2020 & 2027
  • SAUDI ARABIA
    • TABLE 274: Saudi Arabia Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 275: Saudi Arabia Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 276: Saudi Arabia 15-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2012, 2020 & 2027
    • TABLE 277: Saudi Arabia Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 278: Saudi Arabia Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 279: Saudi Arabia 15-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2012, 2020 & 2027
    • TABLE 280: Saudi Arabia Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 281: Saudi Arabia Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 282: Saudi Arabia 15-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2012, 2020 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 283: UAE Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 284: UAE Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 285: UAE 15-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2012, 2020 & 2027
    • TABLE 286: UAE Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 287: UAE Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 288: UAE 15-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2012, 2020 & 2027
    • TABLE 289: UAE Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 290: UAE Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 291: UAE 15-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2012, 2020 & 2027
  • REST OF MIDDLE EAST
    • TABLE 292: Rest of Middle East Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 293: Rest of Middle East Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 294: Rest of Middle East 15-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2012, 2020 & 2027
    • TABLE 295: Rest of Middle East Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 296: Rest of Middle East Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 297: Rest of Middle East 15-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2012, 2020 & 2027
    • TABLE 298: Rest of Middle East Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 299: Rest of Middle East Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 300: Rest of Middle East 15-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2012, 2020 & 2027
  • AFRICA
    • TABLE 301: Africa Current & Future Analysis for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 302: Africa Historic Review for Venous Stents by Technology - Iliac Vein Stent Technology and Wallstent Technology Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 303: Africa 15-Year Perspective for Venous Stents by Technology - Percentage Breakdown of Value Sales for Iliac Vein Stent Technology and Wallstent Technology for the Years 2012, 2020 & 2027
    • TABLE 304: Africa Current & Future Analysis for Venous Stents by Application - Leg, Chest, Abdomen and Arm - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 305: Africa Historic Review for Venous Stents by Application - Leg, Chest, Abdomen and Arm Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 306: Africa 15-Year Perspective for Venous Stents by Application - Percentage Breakdown of Value Sales for Leg, Chest, Abdomen and Arm for the Years 2012, 2020 & 2027
    • TABLE 307: Africa Current & Future Analysis for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 308: Africa Historic Review for Venous Stents by Disease Indication - Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 309: Africa 15-Year Perspective for Venous Stents by Disease Indication - Percentage Breakdown of Value Sales for Chronic Deep Vein Thrombosis, Post Thrombotic Syndrome, May-Thurner Syndrome, Hemodialysis/Arteriovenous Fistulae and Other Disease Indications for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 43